Pomalyst (pomalidomide) — Medica
Primary central nervous system lymphoma
Initial criteria
- Patient has relapsed or refractory disease OR is not a candidate for high-dose methotrexate OR has had intolerance to high-dose methotrexate
Approval duration
1 year